This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Zimmer Biomet, Paragon 28 received German merger clearance, SEC filing says

( February 27, 2025, 23:33 GMT | Official Statement) -- MLex Summary: Zimmer Biomet's acquisition of Paragon 28 was approved by the German Federal Cartel Office on Feb. 24, according to a filing submitted to the US Securities and Exchange Commission. The companies' US premerger antitrust form was submitted on Feb. 7, and the merging parties are obligated to obtain antitrust, competition and foreign investment clearance within South Africa, Germany and Italy, according to their SEC filing. See SEC filing excerpt below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login